166 related articles for article (PubMed ID: 7747994)
1. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
[TBL] [Abstract][Full Text] [Related]
2. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
[TBL] [Abstract][Full Text] [Related]
3. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
Simha M; Menon M; Doctor V
Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
Dube MK; Govil A
Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
[TBL] [Abstract][Full Text] [Related]
8. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
9. Argyrophilic nucleolar organizer regions and proliferating cell nuclear antigen/cyclin in Kaposi's sarcoma. Comparison with morphology and with immunoperoxidase staining for factor VIII-related antigen.
Haupt HM; Stern JB; Multhaupt H; Newman HW
Arch Pathol Lab Med; 1995 Jun; 119(6):538-41. PubMed ID: 7605171
[TBL] [Abstract][Full Text] [Related]
10. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
Babu M; Mathur M; Gupta SD; Chattopadhyay TK
Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
Agarwal PK; Mehrotra A; Chandra T
Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
[TBL] [Abstract][Full Text] [Related]
14. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach.
Kakeji Y; Maehara Y; Orita H; Emi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
J Am Coll Surg; 1996 Jun; 182(6):482-7. PubMed ID: 8646347
[TBL] [Abstract][Full Text] [Related]
15. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of AgNORs in breast cancer].
Aubele M; Auer G; Jütting U
Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
[TBL] [Abstract][Full Text] [Related]
17. AgNOR counts have no prognostic value in breast cancer.
Toikkanen S; Joensuu H
J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490
[TBL] [Abstract][Full Text] [Related]
18. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
20. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
